FDA Approves GLYBURIDE-METFORMIN HYDROCHLORIDE — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals received FDA approval in 2009 for generic glyburide/metformin hydrochloride, expanding access to this widely prescribed diabetes therapy. This action is expected to intensify generic competition in the oral antidiabetic market, aiding cost reduction but challenging branded pricing structures.